People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a yearlong campaign to ...

Doctors explain the differences between the Wegovy pill and injection in terms of efficacy, side effects, and more. They ...

As use of GLP-1 medications surges, tools like Weight Loss Buddy emerge as critical infrastructure for sustaining ...

The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in supposedly “blind” drug trials. So now, when those participants don’t drop ...

A new study suggests that almost half of people stopping GLP-1 weight-loss drugs may keep the weight off. However, many of these people continued other forms of treatment after stopping GLP-1 drugs.

Dosage adjustments for GLP-1s are a normal part of treatment, helping the body adapt and minimize side effects while optimizing benefits for weight loss. Doctors may increase your GLP-1 dose if weight ...

Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...

GLP-1 medications, such as Ozempic, Zepbound and Wegovy, have emerged as a significant advancement in the treatment of various conditions, including Type 2 diabetes, heart ...

As the popularity of weight-loss drugs continues to boom, it has opened the door for scammers eager to dupe people into buying fake versions of the medications. The Better Business Bureau has issued a ...

In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...

The Wu administration is considering dropping GLP-1 coverage for weight loss for City of Boston employees due to ...